Podcasts about alcohol research centre

The World Health Organization says smoking is the leading cause of global preventable death, killing up to 8 million people prematurely every year—far more than die in wars and conflicts. Yet the emotions evoked by national and international anti-smoking campaigns and the impact of those emotions has never been fully studied until now. HKS Professor Jennifer Lerner, a decision scientist who studies emotion, and Vaughan Rees, the director for the Center for Global Tobacco Control at the Harvard Chan School of Public Health, say their research involving actual smokers in the lab shows that sadness—the emotion most often evoked in anti-smoking ads—can actually induce people to smoke more. Lerner and Rees' research also found that evoking gratitude, an emotion that appears to function in nearly the exact opposite manner to sadness, made people want to smoke less and made them more likely to join a smoking-cessation program. Lerner and Rees join host Ralph Ranalli on the latest episode of the HKS PolicyCast to discuss their research and to offer research-backed policy recommendations—including closer collaboration between researchers who study emotion science, which is also known as affective science, and agencies like the Centers for Disease Control.Policy Recommendations:Jennifer Lerner's Policy Recommendations:Foster active communication and collaboration between researchers and public health agencies (e.g., CDC, FDA) to co-create health communications that integrate the latest insights from affective science.Increase awareness among lawmakers and public health policymakers that affective science has progressed beyond intuition to research-validated models that can be predictive and beneficial for behavior change.Vaughan Rees' Policy Recommendations:Expand research into integrating emotion-based strategies, such as gratitude exercises, into school-based prevention programs for adolescents to reduce the risk of tobacco and other substance use, as well as risky sexual behaviors.Introduce research-backed, emotion-based components in cessation counseling and support systems, helping individuals better manage high-risk situations and maintain abstinence after quitting.Dr. Jennifer Lerner is the Thornton F. Bradshaw Professor of Public Policy, Management and Decision Science at the Harvard Kennedy School.She is the first psychologist in the history of the Harvard Kennedy School to receive tenure.  Lerner, who also holds appointments in Harvard's Department of Psychology and Institute for Quantitative Social Sciences, conducts research that draws insights from psychology, economics, and neuroscience and aims to improve decision making in high-stakes contexts. Together with colleagues, Lerner developed a theoretical framework that successfully predicts the effects of specific emotions on specific judgment and choice outcomes. Among other honors, Lerner received the Presidential Early Career Award for Scientists and Engineers (PECASE), the highest honor bestowed by the U.S. government to scientists and engineers in early stages of their careers. Lerner earned her Ph.D. in psychology from the University of California–Berkeley and was awarded a National Institutes of Health postdoctoral fellowship at UCLA. She joined the Harvard faculty and received tenure in 2007, and from 2018-2019 she took a temporary leave from Harvard to serve as the Chief Decision Scientist for the United States Navy.Vaughan Rees is Director of the Center for Global Tobacco Control at the Harvard T.H. Chan School of Public Health. The center's mission is to reduce the global burden of tobacco-related death and disease through training, research, and the translation of science into public health policies and programs. Rees also directs the Tobacco Research Laboratory at the Harvard Chan School, where the design and potential for dependence of tobacco products are assessed. Studies examine the impact of dependence potential on product use and individual risk, to inform policy and other interventions to control tobacco harms. Rees also leads an NIH funded study which seeks to reduce secondhand smoke exposure among children from low income and racially/ethnically diverse backgrounds. His academic background is in health psychology (substance use and dependence), and he trained at the National Drug and Alcohol Research Centre at the University of New South Wales in Sydney, Australia, and did postdoctoral training through the National Institute on Drug Abuse in the United States.Note: Lerner and Rees collaborated on this research with former HKS doctoral student Charlie Dorison, who is now an assistant professor at Georgetown University, and former HKS doctoral student Ke Wang, who is now a postdoctoral fellow at the University of Virginia. Both were co-authors on the research paper on sadness and the research paper on gratitude, which were both published in the Proceedings of the National Academy of Sciences. Ralph Ranalli of the HKS Office of Communications and Public Affairs is the host, producer, and editor of HKS PolicyCast. A former journalist, public television producer, and entrepreneur, he holds an AB in Political Science from UCLA and an MS in Journalism from Columbia University.Design and graphics support is provided by Laura King, Lydia Rosenberg, Delane Meadows and the OCPA Design Team. Social media promotion and support is provided by Natalie Montaner and the OCPA Digital Team. Editorial support is provided by Nora Delaney and Robert O'Neill of the OCPA Editorial Team. Administrative support is provided by Lilly Wainaina.  

Professor Don Weatherburn from the National Drug and Alcohol Research Centre speaks to John as lead author on research which found as gambling profits grew across NSW, crime increased with it. See omnystudio.com/listener for privacy information.

Ketamine use is growing among young Australian party and festival goers as a cut-price alternative to drugs like cocaine and ecstacy. National wastewater monitoring has found consumption of ketamine rose to a record high last year, but it comes with serious risks. In this episode of The Briefing, we're joined by Dr Monica Barratt, a social scientist at the National Drug and Alcohol Research Centre at the University of New South Wales to find out what the risks are, and how to cope with the drug's side effects. Headlines: US to redesignate Houthis as terrorists King Charles to undergo prostate treatment Atlassian shows WFH policy has not hit productivity Djokovic slams crowd during tough Aus Open match Follow The Briefing:Instagram: @thebriefingpodcast Facebook: TheBriefingNewsAUTwitter: @TheBriefingAUSee omnystudio.com/listener for privacy information.

Back in October the world was saddened to learn that Friends star Matthew Perry had died. And earlier this week, a toxicology report was made public showing that the actor had Ketamine in his system when he died in his hot tub in LA.  In this episode of The Quicky, we ask an expert what is ketamine, and why would a known drug addict be treated with a potentially addictive drug? Subscribe to Mamamia GET IN TOUCH Feedback? We're listening! Call the pod phone on 02 8999 9386 or email us at podcast@mamamia.com.au CONTACT US Got a topic you'd like us to cover? Send us an email at thequicky@mamamia.com.au CREDITS  Host: Claire Murphy With thanks to:  Dr Julaine Allan - Associate Professor of Mental Health and Addictions at the Rural Health Research Institute of Charles Sturt University and Senior Visiting Fellow at the National Drug and Alcohol Research Centre, at the University of New South Wales. Producer: Claire Murphy Executive Producer: Kally Borg Audio Producer: Jacob RoundBecome a Mamamia subscriber: https://www.mamamia.com.au/subscribeSee omnystudio.com/listener for privacy information.

Wayne Hall is Emeritus Professor at the National Centre for Youth Substance Use Research at the University of Queensland. He was a Visiting Professor at the National Addiction Centre, Kings College London (2009-2019), the London School of Hygiene and Tropical Medicine (2010-2021); and the National Drug and Alcohol Research Centre, UNSW (since 2001). Wayne has advised the World Health Organization on: the health effects of cannabis use; the effectiveness of drug substitution treatment; the scientific quality of the Swiss heroin trials; the contribution of illicit drug use to the global burden of disease; and the ethical implications of genetic and neuroscience research on addiction. --- Support this podcast: https://podcasters.spotify.com/pod/show/out-of-the-blank/support

Fentanyl is described as one of the deadliest opioids in the world, and on Friday we found out that's what killed Gangsta's Paradise rapper Coolio. With Fentanyl now an epidemic in the US, there are fears the drug may make its way down to our shores with border police already intercepting a major shipment, the equivalent of more than 5 million fatal doses.  In this episode of The Quicky we find out what makes it so deadly, and why Fentanyl is being touted as worse than heroin as overdose deaths climb. Subscribe to Mamamia GET IN TOUCH Feedback? We're listening! Call the pod phone on 02 8999 9386 or email us at podcast@mamamia.com.au CONTACT US Got a topic you'd like us to cover? Send us an email at thequicky@mamamia.com.au CREDITS  Host: Claire Murphy With thanks to:  Kate Ferry - Assistant Commissioner of The Australian Federal Police  Julaine Allan - Associate Professor of Mental Health and Addictions at the Rural Health Research Institute of Charles Sturt University and Senior Visiting Fellow at the National Drug and Alcohol Research Centre, at the University of New South Wales.  Producer: Claire Murphy Executive Producer: Kally Borg Audio Producer: Thom LionBecome a Mamamia subscriber: https://www.mamamia.com.au/subscribeSee omnystudio.com/listener for privacy information.

Vol 215, Issue 9: 1 November 2021. Professor Shane Darke is from the National Drug and Alcohol Research Centre at UNSW Sydney. He discusses trends in barbiturate use over the past two decades. With MJA news and online editor, Cate Swannell. WARNING: This podcast contains discussions of self-harm and suicide. If this raises issues for you, please reach out for help -- DRS4DRS: 1300 374 377; Lifeline 13 11 14; beyondblue: 1300 22 4636; Suicide Call Back Service: 1300 659 467. Professor Darke's research can be found at https://www.mja.com.au/journal/2021/216/2/barbiturate-related-hospitalisations-drug-treatment-episodes-and-deaths ...  

In this episode of Psych Matters, Associate Professor Mat Coleman and his guests discuss Smoking Cessation & E-Cigarettes.Joining in the discussion are Professor Hayden McRobbie and Dr Mark Montebello.Associate Professor Mat Coleman is the Clinical Director of the Great Southern Mental Health Service (WA Country Health Service) based out of Albany WA. He is also the inaugural chair of Rural and Remote Mental Health Practice for the Rural Clinical School WA (University of Western Australia) and is a Commissioner with the National Mental Health Commission. Mat is a member of the Faculty of Addiction Psychiatry, and the Child and Adolescent Faculty of the RANZCP and is the current chair of the Section of Rural Psychiatry. Professor Hayden McRobbie, MB ChB (Otago), PhD (London), FASLMHayden has worked in the field of behavioural medicine for more than 20 years and is a senior clinician with a specialist interest in lifestyle medicine. He holds a medical degree from the University of Otago, a doctorate from the University of London, and is Professor in Public Health Interventions at the National Drug and Alcohol Research Centre, UNSW, and a Fellow of the Australasian Society for Lifestyle Medicine. Hayden has played a key role in Tobacco Control in New Zealand, and his current work includes prevention and management of long-term conditions, with a particular focus on improving health outcomes for Māori in New Zealand. Hayden McRobbie has received honoraria for speaking at smoking cessation meetings and attending advisory board meetings that have been organised by Pfizer Dr Mark Montebello is the Clinical Director of the Northern Sydney Local Health District Drug and Alcohol Service. He is a Psychiatrist, an Addiction Medicine Specialist, a Conjoint Senior Lecturer at the National Drug and Alcohol Research Centre, and a Clinical Senior Lecturer, Discipline of Addiction Medicine, Northern Clinical School at the University of Sydney. Dr Montebello's research interests include novel treatments for substance use disorders including nicotine use disorder withdrawal management in drug and alcohol settings. He was the Psychiatry Board Member for the Australian Association of Smoking Cessation Professionals. Mark Montebello has received honoraria for speaking at smoking cessation meetings and attending advisory board meetings that have been organised by Pfizer.Feedback:If you have a topic suggestion or would like to participate in a future episode of Psych Matters, we'd love to hear from you.Please contact us by email at: psychmatters.feedback@ranzcp.orgDisclaimer:This podcast is provided to you for information purposes only and to provide a broad public understanding of various mental health topics.  The podcast may represent the views of the author and not necessarily the views of The Royal Australian and New Zealand College of Psychiatrists ('RANZCP'). The podcast is not to be relied upon as medical advice, or as a substitute for medical advice, does not establish a doctor-patient relationship and should not be a substitute for individual clinical judgement.  By accessing The RANZCP's podcasts you also agree to the full terms and conditions of the RANZCP's Website. Expert mental health information and finding a psychiatrist in Australian or New Zealand is available on the RANZCP's Your Health In Mind Website.

Don Weatherburn is now a Professor at Australia's National Drug and Alcohol Research Centre, but for most of his career ran the New South Wales Bureau of Crime Statistics and Research in Sydney. There he played a pivotal role informing crime and policing policy at the highest levels of government. We talk about his experience and insights working with practitioners in such a high profile public capacity. He is on twitter @DonWeatherburn

On 13 January 2020, Thailand confirmed the first known case of COVID-19 outside of China. As one of the world's most popular tourism destinations, with the majority of its travellers coming from China, this news came as no surprise. One year on, COVID-19 cases and related deaths have remained remarkably low in Thailand, and the country's management of the pandemic has been hailed as a striking success. So what's the secret behind Thailand's COVID-19 response? Dr Anjalee Cohen joined Dr Natali Pearson to explore the many factors that have contributed to Thailand's success in managing COVID-19 thus far, including the country's long history of public healthcare, the overturning of medical elitism, the influence of certain cultural practices, and the critical role played by Thailand's village health volunteers. Anjalee Cohen is a senior lecturer in the anthropology department at the University of Sydney. She joined the department in 2010 following research positions at the Brain and Mind Centre, University of Sydney, and the National Drug and Alcohol Research Centre, University of New South Wales. She specialises in medical anthropology and Northern Thailand. She has published on youth mental healthcare experiences in Australia, methamphetamine use among northern Thai youth, as well as northern Thai youth subcultures, including violent youth gangs. She is author of Youth Culture and Identity in Northern Thailand: Fitting in and sticking out (Routledge 2020), which explores how young people in urban Chiang Mai construct a sense of community and identity at the intersection of global capitalism, national ideologies and local culture. Her current research focuses on the role and success of Thailand's village health volunteers in preventing and controlling the COVID-19 pandemic. For more information or to browse additional resources, visit the Sydney Southeast Asia Centre's website: www.sydney.edu.au/sseac. Learn more about your ad choices. Visit megaphone.fm/adchoices

On 13 January 2020, Thailand confirmed the first known case of COVID-19 outside of China. As one of the world's most popular tourism destinations, with the majority of its travellers coming from China, this news came as no surprise. One year on, COVID-19 cases and related deaths have remained remarkably low in Thailand, and the country's management of the pandemic has been hailed as a striking success. So what's the secret behind Thailand's COVID-19 response? Dr Anjalee Cohen joined Dr Natali Pearson to explore the many factors that have contributed to Thailand's success in managing COVID-19 thus far, including the country's long history of public healthcare, the overturning of medical elitism, the influence of certain cultural practices, and the critical role played by Thailand's village health volunteers. Anjalee Cohen is a senior lecturer in the anthropology department at the University of Sydney. She joined the department in 2010 following research positions at the Brain and Mind Centre, University of Sydney, and the National Drug and Alcohol Research Centre, University of New South Wales. She specialises in medical anthropology and Northern Thailand. She has published on youth mental healthcare experiences in Australia, methamphetamine use among northern Thai youth, as well as northern Thai youth subcultures, including violent youth gangs. She is author of Youth Culture and Identity in Northern Thailand: Fitting in and sticking out (Routledge 2020), which explores how young people in urban Chiang Mai construct a sense of community and identity at the intersection of global capitalism, national ideologies and local culture. Her current research focuses on the role and success of Thailand's village health volunteers in preventing and controlling the COVID-19 pandemic. For more information or to browse additional resources, visit the Sydney Southeast Asia Centre's website: www.sydney.edu.au/sseac. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine

On 13 January 2020, Thailand confirmed the first known case of COVID-19 outside of China. As one of the world's most popular tourism destinations, with the majority of its travellers coming from China, this news came as no surprise. One year on, COVID-19 cases and related deaths have remained remarkably low in Thailand, and the country's management of the pandemic has been hailed as a striking success. So what's the secret behind Thailand's COVID-19 response? Dr Anjalee Cohen joined Dr Natali Pearson to explore the many factors that have contributed to Thailand's success in managing COVID-19 thus far, including the country's long history of public healthcare, the overturning of medical elitism, the influence of certain cultural practices, and the critical role played by Thailand's village health volunteers. Anjalee Cohen is a senior lecturer in the anthropology department at the University of Sydney. She joined the department in 2010 following research positions at the Brain and Mind Centre, University of Sydney, and the National Drug and Alcohol Research Centre, University of New South Wales. She specialises in medical anthropology and Northern Thailand. She has published on youth mental healthcare experiences in Australia, methamphetamine use among northern Thai youth, as well as northern Thai youth subcultures, including violent youth gangs. She is author of Youth Culture and Identity in Northern Thailand: Fitting in and sticking out (Routledge 2020), which explores how young people in urban Chiang Mai construct a sense of community and identity at the intersection of global capitalism, national ideologies and local culture. Her current research focuses on the role and success of Thailand's village health volunteers in preventing and controlling the COVID-19 pandemic. For more information or to browse additional resources, visit the Sydney Southeast Asia Centre's website: www.sydney.edu.au/sseac.

On 13 January 2020, Thailand confirmed the first known case of COVID-19 outside of China. As one of the world's most popular tourism destinations, with the majority of its travellers coming from China, this news came as no surprise. One year on, COVID-19 cases and related deaths have remained remarkably low in Thailand, and the country’s management of the pandemic has been hailed as a striking success. So what's the secret behind Thailand's COVID-19 response? Dr Anjalee Cohen joined Dr Natali Pearson to explore the many factors that have contributed to Thailand’s success in managing COVID-19 thus far, including the country’s long history of public healthcare, the overturning of medical elitism, the influence of certain cultural practices, and the critical role played by Thailand’s village health volunteers. Anjalee Cohen is a senior lecturer in the anthropology department at the University of Sydney. She joined the department in 2010 following research positions at the Brain and Mind Centre, University of Sydney, and the National Drug and Alcohol Research Centre, University of New South Wales. She specialises in medical anthropology and Northern Thailand. She has published on youth mental healthcare experiences in Australia, methamphetamine use among northern Thai youth, as well as northern Thai youth subcultures, including violent youth gangs. She is author of Youth Culture and Identity in Northern Thailand: Fitting in and sticking out (Routledge 2020), which explores how young people in urban Chiang Mai construct a sense of community and identity at the intersection of global capitalism, national ideologies and local culture. Her current research focuses on the role and success of Thailand’s village health volunteers in preventing and controlling the COVID-19 pandemic. For more information or to browse additional resources, visit the Sydney Southeast Asia Centre’s website: www.sydney.edu.au/sseac. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/southeast-asian-studies

On 13 January 2020, Thailand confirmed the first known case of COVID-19 outside of China. As one of the world's most popular tourism destinations, with the majority of its travellers coming from China, this news came as no surprise. One year on, COVID-19 cases and related deaths have remained remarkably low in Thailand, and the country’s management of the pandemic has been hailed as a striking success. So what's the secret behind Thailand's COVID-19 response? Dr Anjalee Cohen joined Dr Natali Pearson to explore the many factors that have contributed to Thailand’s success in managing COVID-19 thus far, including the country’s long history of public healthcare, the overturning of medical elitism, the influence of certain cultural practices, and the critical role played by Thailand’s village health volunteers. Anjalee Cohen is a senior lecturer in the anthropology department at the University of Sydney. She joined the department in 2010 following research positions at the Brain and Mind Centre, University of Sydney, and the National Drug and Alcohol Research Centre, University of New South Wales. She specialises in medical anthropology and Northern Thailand. She has published on youth mental healthcare experiences in Australia, methamphetamine use among northern Thai youth, as well as northern Thai youth subcultures, including violent youth gangs. She is author of Youth Culture and Identity in Northern Thailand: Fitting in and sticking out (Routledge 2020), which explores how young people in urban Chiang Mai construct a sense of community and identity at the intersection of global capitalism, national ideologies and local culture. Her current research focuses on the role and success of Thailand’s village health volunteers in preventing and controlling the COVID-19 pandemic. For more information or to browse additional resources, visit the Sydney Southeast Asia Centre’s website: www.sydney.edu.au/sseac. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Jack Revell from Drugswrap talks the week in drug news with us.Follow Drugswrap on TwitterDr. Monica Barratttwitter.com/monicabarratt(link is external)Dr. Monica Barratt is a social scientist, focusing on alcohol and other drug policy, especially around how drug markets operate in the online world. Monica works with the Drug Policy Modelling Program, part of Australia's National Drug and Alcohol Research Centre at the University of New South Wales and currently a senior research fellow with RMIT UniversityDr. Nicole Leetwitter.com/drnicolelee(link is external)Dr Nicole Lee is psychologist, with expertise in alcohol and other drug policy and practice. Nicole is an adjunct professor at the National Drug Research Institute at Curtin University, a member of the Australian National Advisory Council on Alcohol and Drugs and the Director of 360 Edge, a specialist alcohol and other drugs consultancy which helps bring research into policy and practice. Global Drug Survey COVID-19 EditionThe GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health and relationships. Over 55,000 people took part. The survey ran for 7 weeks in (May – June 2020)VIEW THE GLOBAL DRUG SURVEY RESULTS(link is external)National Drug Strategy Household Survey 2019 Australian Institute of Health and Welfare(link is external)

Jack Revell from Drugswrap talks the week in drug news with us.Follow Drugswrap on TwitterDr. Monica Barratttwitter.com/monicabarrattDr. Monica Barratt is a social scientist, focusing on alcohol and other drug policy, especially around how drug markets operate in the online world. Monica works with the Drug Policy Modelling Program, part of Australia's National Drug and Alcohol Research Centre at the University of New South Wales and currently a senior research fellow with RMIT UniversityDr. Nicole Leetwitter.com/drnicoleleeDr Nicole Lee is psychologist, with expertise in alcohol and other drug policy and practice. Nicole is an adjunct professor at the National Drug Research Institute at Curtin University, a member of the Australian National Advisory Council on Alcohol and Drugs and the Director of 360 Edge, a specialist alcohol and other drugs consultancy which helps bring research into policy and practice. Global Drug Survey COVID-19 EditionThe GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health and relationships. Over 55,000 people took part. The survey ran for 7 weeks in (May – June 2020)VIEW THE GLOBAL DRUG SURVEY RESULTSNational Drug Strategy Household Survey 2019 Australian Institute of Health and Welfare

This week we discuss whether Australia’s coronavirus prevention measures are fit for purpose and take a look at the challenges facing victims of family violence who are stuck at home due to the pandemic.Are Australia’s COVID-19 prevention measures sustainable? How can policymakers get the balance right in the coming months and maybe years while the world searches for a vaccine? And what has been the impact of the pandemic on those living in abusive relationships? On this episode of Policy Forum Pod, Professor Sharon Bessell chats with infectious diseases expert Professor Peter Collignon AM about Australia’s COVID-19 prevention measures, before Dr Bianca Calabria joins us to discuss family violence during the pandemic.Professor Peter Collignon AM is an infectious diseases physician and microbiologist at the Canberra Hospital. He is currently Executive Director of ACT Pathology and a Professor at The Australian National University Medical School.Dr Bianca Calabria is a Research Fellow at the Research School of Population Health at The Australian National University and a Conjoint Lecturer at the National Drug and Alcohol Research Centre at University of New South Wales. She also works as a psychologist, with people who have experienced trauma, particularly survivors of domestic violence.Professor Sharon Bessell is a Professor at Crawford School of Public Policy, where she is co-leader of the ANU Individual Deprivation Measure (IDM) team. The IDM is a new, gender-sensitive and multidimensional measure of poverty.Policy Forum Pod is available on Acast, Apple Podcasts, Spotify, Stitcher, Subscribe on Android or wherever you get your podcasts. We’d love to hear your feedback for this podcast series! Send in your questions, comments, or suggestions for future episodes to podcast@policyforum.net. You can also Tweet us @APPSPolicyForum or join us on the Facebook group. See acast.com/privacy for privacy and opt-out information.

Pain lets us know when there is something wrong, but sometimes our brains can trick us. Mai Lam/The Conversation NY-BD-CC, CC BY-SAAs many as one in five Australians suffer from chronic and recurring pain. But despite its prevalence, it’s not always easy to find the help you need to manage it. “When I went through medical school, we had about one hour on acute pain. And the whole concept of chronic pain and how it’s so very different from acute pain was not something that was ever on our horizon,” pain expert Professor Fiona Blyth says in the latest episode of The Conversation podcast Trust Me, I’m An Expert. On Trust Me, I’m An Expert, we ask researchers to take us behind the headlines and walk us through the research on issues making news. Our latest episode takes a deep dive into the science of pain: what it is and what the evidence really says about how to manage it. Today, we’re talking about: What exactly is pain? Professor Lorimer Moseley explains to Deputy Health Editor Sasha Petrova what really happens in your body when you experience pain. Pain is meant to keep us safe, he says, but unfortunately your brain can play tricks on you, making you feel pain even when there’s no real need for it. Bioplasticity – the body and brain’s ability to train and change itself – could hold the key, he says. Here’s a taste: Professor Lorimer Moseley on bioplasticity. After the codeine crackdown, what now? We asked student Sabine Hamad, who has thus far managed her chronic and recurring pain with occasional codeine use, to join us in the studio with pain experts Professor Michael Nicholas and Professor Fiona Blyth, to talk about the recent ban on over the counter sales of codeine – and the alternatives. Professor Michael Nicholas on making sense of someone’s pain. Australia’s opioid issues Ben Ansell spoke to Dr Suzanne Nielsen, a lead researcher from the National Drug and Alcohol Research Centre, about growing concern around opioid addiction in Australia. Dr Suzanne Nielsen on addiction. Talking about suicide and self-harm in schools can save lives Our last story is about a different kind of pain. Education editor Sophie Heizer spoke to Dr Sarah Stanford, whose research focuses on self-harm in schools, churches, and other community settings. Dr Stanford said there are helpful – and harmful – ways for schools to talk about suicide: Dr Sarah Stanford on suicide and self-harm prevention strategies. For support, call Beyond Blue on 1300 22 4636, Lifeline on 13 11 14 or visit Headspace, which has information for schools, young people, and family and friends. Trust Me, I’m An Expert is out at the start of every month. Find us and subscribe in Apple Podcasts, Pocket Casts or wherever you get your podcasts. Additional audio David Szesztay, Backward, Free Music Archive Kindergarten, Unkle Ho, from Elefant Traks Poddington Bear, Storm Passing from Free Music Archive Poddington Bear, Paper Boat, from Free Music Archive Poddington Bear, Waves, from Free Music Archive Letmeknowyouanatole, Free Music Archive Komiku, Resolution, Free Music Archive Kosta T, Free Music Archive Audiobinger, Stress, Free Music Archive. Blue Dot Sessions, Paper Feather A Life in Pictures by David Hilowitz

This week on Brainwaves, the team talks to Associate Professor Katherine Mills on the topic of substance abuse. Katherine works at the National Drug and Alcohol Research Centre where her research focuses on the co-existence of mental illness and substance use. 

Broadcast live from the Entheogenesis Australis (EGA) 2017 Psychedelic Symposium at Holmesglen in Eildon.Hosted by Nick WallisWith blanket bans on psychoactives increasing, cognitive liberty is in chains. Where does reform for laws covering psychedelics fit within drug law reform? In an environment where evidence is not the drive for policy how do we keep policy makers accountable? What have we learned recent work and development? How can you help with the next steps? A number of individuals who have been involved with drug law and policy activism will join a panel to discuss strategies for reform.The panel will bring along some recent examples of activism and workshop these with the audience, drawing out successful strategies, unsuccessful strategies and discussing potential future campaigns.PANELRICK DOBLINIn the mid 1970s MDMA, then known as Adam was used quietly in psychotherapy. In the 1980s, growing recreational use of Ecstasy led to the criminalization of the drug and the formation of MAPS in 1986. Now, MAPS is about to embark on FDA-approved Phase 3 research to make MDMA-assisted psychotherapy a legal treatment for PTSD. This talk will discuss the historical implications of MDMA use and the plans for ongoing clinical research.Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard's Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master's thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary's Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and one of three children (two in college).MONICA BARRATTDR MONICA BARRATT is a social scientist at the Drug Policy Modelling Program, part of Australia's National Drug and Alcohol Research Centre at the University of New South Wales. Monica's work examines the social and public health implications of digital technologies for people who use illicit and emerging psychoactive drugs. Research topics emerging from this interest include online drug markets or cryptomarkets and policy responses to novel psychoactive substance evolution. She specialises in engaging hard-to-reach networks and groups in digital spaces in conversations about research and policy, to inform policy change. Monica also serves as an Editor for policy-related articles at the International Journal of Drug Policy, and as the Director of Research at the international drug harm reduction community Bluelight.org. Monica is a lead researcher for the Global Drug Survey. She is also a regular attendee and contributor to EGA, from the mid-2000s.NICK KENTNICK KENT works as a secondary school teacher in the areas of languages and the humanities. He is currently completing his Masters through research at the Melbourne Graduate School of Education, where he is undertaking a critical discourse analysis of school policies and resources as they relate to drug education, comparing both local and international examples. After completing the Grad. Dip in Teaching in 2015, Nick was perplexed at the lack of teacher training around student drug use and the silence of the education system on this issue, as well as the slow pace of drug reform more broadly. Inspired to learn more, and to advocate and research this area further, Nick helped found Students for Sensible Drug Policy Australia in 2016, setting up their second chapter at the University of Melbourne. Nick was instrumental in the UniMelb chapter's work in setting up a harm reduction program that would supply re-agent drug checking kits to students free of charge through the Student Union, and has travelled to numerous international conferences to represent this globally significant program. Nick draws upon his experience in nightclub and festival communities, as well as his experience volunteering with DanceWize as a Peer Educator and his policy and international experience with SSDP in both his teaching and his research.FIONA MEASHAMFiona Measham is co-founder & co-Director of ‘The Loop’. The Loop conducts forensic testing of drugs at UK festivals and nightclubs and provides associated welfare support. Fiona Measham was appointed Professor of Criminology in the School of Applied Social Sciences at Durham University in 2012. Fiona has conducted research for over two decades across a broad area of criminology and social policy, exploring changing trends in legal and illegal drugs; the night time economy and the socio-cultural context to consumption; gender; the regulation and policing of intoxication; electronic music scenes and club cultures; issues of deterrence, displacement and desistance; and broader policy implications. A key feature of her research has been the development of in-situmethods of data collection in pubs, clubs and festivals, a working environment with which she is familiar, having spent her early adulthood working in bars and clubs across several continents in various guises.BEN SESSADR BEN SESSA (MBBS BSc MRCPsych) is a consultant child and adolescent psychiatrist working in adult addiction services and with custodial detained young people in a secure adolescent setting. He trained at UCL medical school, graduating in 1997. He is interested in the developmental trajectory from child maltreatment to adult mental health disorders. Dr Sessa is currently a senior research fellow at Bristol, Cardiff and Imperial College London Universities, where he is conducting the UK's first clinical studies with MDMA-assisted therapy for the treatment of PTSD and alcohol dependence syndrome. In the last ten years he has worked on several UK-based human pharmacology trials as study doctor or as a healthy subject administering and receiving test doses of LSD, psilocybin, MDMA and ketamine. He is the author of several dozen peer-reviewed articles in the mainstream medical press and has written two books exploring psychedelic medicine; The Psychedelic Renaissance (2012) and To Fathom Hell or Soar Angelic (2015). In speaking publicly at universities and medical conferences, Dr Sessa is outspoken on lobbying for change in the current system by which drugs are classified in the UK, believing a more progressive policy of regulation would reduce the harms of recreational drug use and provide increased opportunities for clinical psychedelic research. He is a co-founder and director of the UK's Breaking Convention conference.

Professor Carla Treloar and Annie Madden chat with Professor Alison Ritter, internationally recognised drug policy scholar and Director of the Drug Policy Modelling Program at the National Drug and Alcohol Research Centre at UNSW. For more info: https://csrh.arts.unsw.edu.au/research/podcast-speakeasy-with-annie-madden-and-carla-treloar/

 This week's show is about upcoming drug law reform around recreational drug use, and what's current in harm reduction approaches.We’ll hear from three guests on this topic, Nevena Spirovska from grassroots campaign High Alert, Stephanie Tzanetis from DanceWize, once a grassroots campaign and now supported by Health Promotion Victoria, and Julaine Allan, an adjunct associate at the National Drug and Alcohol Research Centre.  Music is by Simona Castricum N.B. The US academic referred to Julaine Allan is Dr Daniel Ciccarone, a San Franciso-based public health researcher and physician. Women on the Line does not condone or condemn people who use drugs for their choices. If you are concerned about your drug use or that of a friend, you can call Family Drug Support on 1300 368 186, or check out your state-based service. 

Back from the dusty, sun-drenched pop-up village that is Rainbow Serpent Festival, where the battles for sensible drug policy continue. This episode of Enpsychedelia brings a variety of guests in the studio, on the phone and via Skype to chat about pill testing, Victoria's drug inquiry, post-Rainbow discussion and some psychedelic dreamings.During the past fortnight, Port Phillip City Council voted to support trials of pill testing, following the death and hospitalisation of several people on Chapel Street in Melbourne, potentially caused by unknown novel psychoactive substances (NPS).Guests:US artist, musician and futurist Michael Garfield.Dr. Monica Barratt, Drug Policy Modelling Program at the National Drug and Alcohol Research Centre.Melissa Warner and Dr. Dean Wright of The Australian Psychedelic SocietyMember of the (Victoria) Legislative Council and President of the Australian Sex Party Fiona PattenPort Phillip City Council, Gateway Ward councillor and member of the Victorian Greens Ogy Simic

Ben speaks to the Director of the Drug and Alcohol Research Centre about the mysterious new drug Flakka

0:00:00 Introduction Richard Saunders and Jo Alabaster   0:08:10 Maynard's Spooky Action... Maynards interviews Alex Wodak, a physician and the director of the Alcohol and Drug Service, at St Vincent's Hospital, in Sydney, Australia. He is a notable advocate of drug reform laws. Wodak helped establish the National Drug and Alcohol Research Centre, the NSW Users AIDS Association, and the Australian Society of HIV Medicine. Wodak is President of the Australian Drug Law Reform Foundation and was President of the International Harm Reduction Association.   0:26:26 Professor Brian Schmidt AC, FRS Kevin Davies from Canberra Skeptics catches up with Brian Schmidt for a quick chat after a presentation.    0:31:00 A Week in Science The Royal Institution of Australia (RiAus) is a national scientific not-for-profit organisation with a mission to bring science to people and people to science.   0:36:06 'Wellness Warrior' Jess Ainscough dies from cancer Jo Alabaster and Richard Saunders discuss the sad death of Jess Ainscough who gave up medicine for alternative remedies. 

Michael Farrell, professor and director of the National Drug and Alcohol Research Centre at the University of New South Wales in Sydney, talks to Mabel Chew, The BMJ's practice editor, about prescription of cannabinoids. They discuss the latest evidence on nausea and appetite, when cannabinoids may be effective for chronic pain, and which common problems to watch out for. Read the full article: http://www.bmj.com/content/348/bmj.g2737

Washington has become the first US state to legalise the recreational use of Marijuana. Those over the age of 21 are now able to possess and use up to 28 grams of the drug in private areas. Although some US states do allow cannabis use for medicinal purposes, Washington is the first to legalise it for entertainment. 2SER’s Sam Buckingham-Jones spoke with Professor Alison Ritter, Director of the Drug Policy Modelling Program at the National Drug and Alcohol Research Centre.